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Objective: We are unaware of the extent of antimicrobial stewardship programs (ASPs) among hospitals in
Pakistan, which is a concern given the population size, high use of antibiotics across sectors and increasing
antimicrobial resistance (AMR) rates. Consequently, we sought to address this by undertaking a comprehensive
survey.
Method: In this cross-sectional observational study in Punjab, an instrument of the measure was developed based
on health care facility characteristics and ASPs after an extensive literature review. The questionnaire was
circulated by mail or through drop off surveys to medical superintendents or directors/heads of pharmacy de-
partments of hospitals.
Results: Out of 254, a total of 137 hospitals fully completed the questionnaire - 11 primary, 65 secondary, 46
tertiary and 15 specialized hospitals. The use of antimicrobial prescribing guidelines (68.7%), provision of in-
fectious diseases consultation services (66.4%), clinical pharmacy service (65.7%), use of drug and therapeutics
committees to approve antimicrobial prescribing (65.5%), regular audit by doctors on antimicrobial prescribing
(54.1%) and use of a restricted formulary for antimicrobial (50.4%) were the most common ASPs. However, most
of these activities were only somewhat or moderately successful. Whereas, electronic antimicrobial prescribing
approval systems (15.3%), using a sticker to notify prescribers regarding the need to obtain approval for the
antimicrobial prescribed (16.1%) and participation in the national antimicrobial utilization surveillance program
(19.7%) were only seen in a few hospitals.
Conclusion: Study inferred that there are inadequate ASPs in the hospitals of Pakistan. A multidisciplinary
approach, clinical leadership and availability of motivated and trained individuals are essential elements for the
success of future ASPs.1. Introduction
In this unending battle of microbes against antimicrobials, the mi-
crobes appear to be winning, and the pipeline of new antimicrobials is
near to the end. Antimicrobial resistance (AMR) due to the inappropriate
use of antibiotics is a rising threat, which has caught the attention of
international and national organizations [1, 2, 3]. Reducing antimicro-
bial resistance while maintaining the efﬁcacy of antimicrobials is them 18 May 2019; Accepted 23 Ju
is an open access article under tdream and the instigation of antimicrobial stewardship programs (ASP)
appears the best way to achieve this goal. The United Nations General
Assembly (UNGA) convention held on 21 September 2016 discussed
progress towards Sustainable Development Goals (SDGs) 2030 including
concerns with the shortage of antimicrobials as a consequence of AMR
[4]. The World Health Organization (WHO) surveillance of resistance to
antimicrobials also showed growing AMR along with declining suscep-
tibility of current antimicrobials [5].ly 2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in hospitals are prescribed antimicrobials whilst in hospitals, higher
though in some countries especially those with high rates of HIV, and
around 30–50% of antimicrobial use is seen as irrational [6, 7, 8].
Reducing AMR while maintaining the efﬁcacy of antimicrobials is a key
goal among countries, especially lower and middle-income countries
(LMICs) with high rates of infectious diseases and AMR [9]. ASPs are one
way to improve antibiotic utilization in hospitals [9, 10]. The Infectious
Disease Society of America (IDSA) and the Society of Healthcare Epide-
miology of America (SHEA) endorse ASPs to develop and quantify the
rational use of antibacterials through assessing current use against rec-
ommended guidelines [11, 12]. The Center for Disease Control and
Prevention (CDC) and SHEA both promote the rational use of antimi-
crobials [13]. In line with IDSA, SHEA and CDC, The Joint Commission
(TJC) also recommended features to reduce AMR and irrational antimi-
crobial use [14]. The World Health Assembly also recommended ASPs
for all health-care facilities [5]. ASPs showed effectiveness to subside
the occurrence of microbial infections and colonization with
carbapenem-resistant and extended-spectrum β-lactamase-producing
Gram-negative bacteria, methicillin-resistant Staphylococcus aureus,
multidrug-resistant Gram-negative bacteria and C difﬁcile [15]. A recent
systematic review also demonstrated the positive effect of ASPs with
improving antibiotic use in hospitals [16]. ASPs with multidisciplinary
groups are hardly seen outside of health care settings of high income
countries (HIC) [15]. This is exempliﬁed by the lack of AMS programmes
among hospitals in LMICs [17]. This may be due to the difﬁculties and
challenges with implementing ASPs in LMICs including manpower and
resource issues [9]. At this moment, the international community needs
to step up when it comes to ﬁnancing national action plans that
co-prioritize infection prevention, antimicrobial resistance (AMR) and
ASP [18]. Irrational antibiotic prescribing and the continuous develop-
ment of resistant infections are both serious issues faced by Pakistan [2].
We are unaware of the extent of ASP among hospitals in Pakistan, which
is a concern given the population size, high use of antibiotics across
sectors and increasing AMR rates. Consequently, we sought to address
this by undertaking a comprehensive research programme to assess the
extent of ASPs starting with hospitals within a key province in Pakistan.
The ﬁndings can be used to develop pertinent programmes to address
concerns not only in Punjab but across Pakistan where they exist.
2. Methodology
2.1. Study design and instrument
In this quantitative observational study, a survey was conducted to
evaluate the number of AMS practices and general ASP activities in
Pakistan as well as their perceived impact. An instrument of measure was
developed based on health care facility characteristics and ASPs
following an extensive literature review [11, 12, 14, 19]. The types of
ASPs were broadly grouped into: administration related activities and
antimicrobial use and prescribing-related activities. The participants
subsequently related the perceived effectiveness of the different activities
using a 5-point measure ranging from unsuccessful, somewhat successful,
moderately successful, very and successful and extremely successful.
Face and content validity of the questionnaire was performed by experts
in the ﬁeld of quantitative research. Faced validity was undertaken to
uncover obvious problems and check the relevance of the questionnaire
as it appeared to respondents. In order to cover all relevant issues, con-
tent validity was performed through an extensive literature review.
Cronbach's alpha was used to determine the average correlation of items
or internal consistency in the survey instrument to gauge its reliability.
The value of Cronbach's alpha was 0.791, which is considered acceptable
in social science research. Before full scale study, a pilot study was un-
dertaken and pertinent changes were made to the survey instrument by
removing suggested ﬂaws accordingly. The study was approved by the
University College of Pharmacy, University of the Punjab, Ethics2Committee on Human Research (HEC/1000/PUCP/1925SAMS).
2.2. Inclusion criteria and survey instrument
Punjab, the largest and most populous province, was chosen for this
initial study as a representative area of Pakistan. The survey instrument
was piloted and validated by practicing hospital pharmacists, physicians
and pharmacists/physicians in research and academia before full
implementation. This survey included a variety of facility types repre-
senting the different facilities in Pakistan. All private, charity and public
sector hospitals including primary, secondary, tertiary, and specialized
care hospitals, were contacted. Contact details were obtained from the
Director General Health Services ofﬁce, Department of Health, Govern-
ment of the Punjab, Pakistan. This survey was initially sent out to acute
care facilities (ACFs) with >25 beds. Health care settings with <25 beds
were not included as they are typically located in rural areas, have
inadequate health care services, and are generally linked with a larger
health care settings to encourage patient transfer when required.
2.3. Data collection and analysis
The survey questionnaire was circulated by mail or through drop off
survey to medical superintendents or directors/heads of pharmacy de-
partments from February to May 2018. An introductory e-mail or cover
letter was also sent to highlight the nature and importance of this survey.
The participants were ensured that all collected data would be anony-
mized by using codes in order to ensure conﬁdentiality. Only one
representative from each hospital was invited to complete the survey.
The participants were also requested, where appropriate, to disseminate
this survey link through their contacts or organisations. Either the
medical superintendents or directors of pharmacy departments person-
ally, or their representative, completed the survey. After 2–3 weeks, the
ﬁrst reminder was forwarded with the second and ﬁnal reminder sent
after a further three weeks. Data were analyzed using the latest versions
of Microsoft Excel and SPSS (version 22 IBM, California, USA).
Descriptive statistics (frequency and percentages) was applied on cate-
gorical variables.
3. Results
The response rate was 62.1%, i.e. 168 completed survey forms were
obtained out of a total of 267 sent out. The highest response rate was seen
among public sector hospitals (109, 79.5%) followed by charity (24,
61.5%) and private sector hospitals (35, 44.9%). From the total number
of surveys received, 31 entries were subsequently excluded because the
respondents did not record the information properly. This left a total of
137 hospitals who provided the complete information contained in the
questionnaire: 11 primary, 65 secondary and 61 tertiary hospitals.
Pharmacists accounted for 55.5% (76/137) of the survey returns, phy-
sicians for 22.6% (31/137) and medical superintendents for 21.9% (30/
137). The details of personnel taking part and hospital information are
given in Table 1.
The types of ASPs activities are shown in Tables 2 and 3. The use of
Drug and Therapeutics Committees (DTCs) or equivalent committees to
approve antimicrobial use (65.5%) was the most common
administration-related activity. This was followed by regular auditing by
doctors regarding their antimicrobial prescribing and use (54.1%) and
the use of a restricted formulary for antimicrobials within the hospital
(50.4%). The overall perceived rate of activities to become usuccessful
was very low. However, most of the documented activities were only
somewhat or moderately successful. Only 19.7% of hospitals participated
in the national antimicrobial utilization surveillance program. Nearly
25% of hospitals had established a mechanism for conﬂict resolution in
an event of a disagreement with respect to the prescribing of antimi-
crobials between practitioners and computerized clinical decision sup-
port systems when integrated into the health records at the time of
Table 1
Personal information of respondents.
Characteristics Number Percentage
PERSONAL INFORMATION
Gender
Male 88 64.2
Female 49 35.8
Level of qualiﬁcation/Terminal Degree
Bachelor 75 54.7
Master or Fellowship 62 45.3
Designation
Pharmacist 76 55.5
Physicians 31 22.6
Medical Superintendent 30 21.9
HOSPITAL INFORMATION
Hospital Type
Primary 11 8.0
Secondary 65 47.4
Tertiary 61 44.5
Hospital Ownership
Charity 17 12.4
Private 28 20.4
Public 92 67.2
Area
Rural 37 27.0
Urban 100 73.0
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most of the respondents commented that they use clinical guidelines to
guide their prescribing (68.7%). The provision of infectious diseases
consultation services by infectious diseases clinicians was witnessed inTable 2
Administration-related antimicrobial stewardship activities.
Administration-related activities No. of Respondents - %s in
brackets
Don't
know
No Yes
Drug and Therapeutic Committee or equivalent
Committee approving antimicrobials listing on the
formulary and its associated use
13 (9.5) 35
(25.5)
89
(65.5)
Restricted formulary for antimicrobial prescribing 17
(12.4)
51
(37.2)
69
(50.4)
Locally formulated antimicrobial policy 12 (8.8) 64
(46.5)
61
(44.5)
Regular audit by administrators on the prescribing and use
of antimicrobials
9 (6.6) 68
(49.6)
60
(43.8)
Regular audit by doctors on antimicrobial prescribing and
use
15
(10.9)
48
(35.0)
74
(54.1)
Regular audit by pharmacists on antimicrobial prescribing
and use
8 (5.8) 62
(45.3)
67
(48.9)
Regular audit by nurses on antimicrobial prescribing and
use
14
(10.2)
61
(44.5)
62
(45.3)
Established mechanism for conﬂict resolution in event of
disagreement with respect to use of antimicrobials
between practitioners
17
(12.4)
87
(63.5)
33
(24.1)
Participation in the National Antimicrobial utilization
Surveillance Program
14
(10.2)
96
(70.1)
27
(19.7)
Multidisciplinary antimicrobial stewardship team or
equivalent to coordinate activities in hospital
6 (4.4) 89
(65.0)
42
(30.7)
Computerized Clinical Decision Support Systems
Integrated into the Health Record at the Time of
Prescribing
7 (5.1) 96
(70.1)
34
(24.8)
Routine access to an infectious disease specialist (even in
another hospital if needed)
14
(10.2)
62
(45.3)
61
(44.5)
Routine availability of reagents and discs to perform
sensitivity analyses of specimens
11 (8.0) 62
(45.3)
64
(46.5)
Work with the Microbiology Laboratory to Develop
Stratiﬁed antibiograms
14
(10.2)
82
(59.9)
41
(29.9)
Antibiograms used to develop guidance for the empiric use
of antibiotics within the hospital
7 (5.1) 93
(67.9)
37
(27.0)
Advocate for Rapid Diagnostic Testing for bacteria and
viruses to Optimize Antibiotic Therapy
9 (6.6) 65
(47.4)
63
(46.0)
Develop Facility-Speciﬁc Clinical Guidelines for
Management of Fever and Neutropenia (F&N)
11 (8.0) 78
(56.9)
48
(35.0)
366.4% of hospitals. Clinical pharmacy service was provided in 65.7% of
healthcare facilities. Streamlining or de-escalation (treatment is re-
directed after culture results have been obtained) of antimicrobial ther-
apy and timely conversion of IV to oral antimicrobials were also very
common activities. These activities were perceived to be somewhat very
successful by respondents. Electronic antimicrobial prescribing approval
systems were used in only 15.3% of hospitals surveyed, and only 16.1%
of hospitals were using a sticker to notify prescribers regarding the need
to obtain approval for the antimicrobial prescribed.
4. Discussion
This snapshot has highlighted important results on the exsietnce of
ASPs among private and public sector hospitals in the Punjab region of
Pakistan. Disappointingly, only a limited number hospitals have suc-
cessfully instigated ASP which is a concern for hospitalized patients
within a country [3]. This has also been seen among Pakistani hospitals,
which had not yet fully started ASP initiatives [2], reﬂecting LMICs
generally, which have lower levels of ASPs than developed countries
enhanced by the absence of necessary infrastructures and political
commitment [9, 20]. However, it is encouraging that ASPs are being
developed, and appear successful in LMIC to tackle the challenge of AMR
[10, 21, 22]. Whereas, ASPs are well established in developed countries
which possibly reveals strong historical commitment and leadership on
ASP from their organizations [11, 12].
Regardless of the presence of large well-established public and pri-
vate hospitals across Pakistan, the present study showed that only a few
ASPs exist in most of the hospitals. This may reﬂect limited knowledge ofPerceived success of the activity (only those who answered “Yes” to having the activity
at their institution – with %s vs. total in brackets)
Unsuccessful Somewhat
successful
Moderately
successful
Very
successful
Extremely
successful
3 (2.2) 35 (25.5) 21 (15.3) 22 (16.1) 8 (5.8)
4 (2.9) 17 (12.4) 25 (18.2) 14 (10.2) 9 (6.6)
6 (4.4) 23 (16.8) 11 (8.0) 15 (10.9) 6 (4.4)
7 (5.1) 16 (11.7) 10 (7.3) 19 (13.9) 8 (5.8)
7 (5.1) 16 (11.7) 19 (13.9) 20 (14.6) 12 (8.8)
1 (0.7) 19 (13.9) 20 (14.6) 12 (8.8) 15 (10.9)
5 (3.6) 22 (16.6) 12 (8.8) 17 (12.4) 6 (4.4)
– 12 (8.8) 8 (5.8) 9 (6.6) 4 (2.9)
2 (1.5) 7 (5.1) 6 (4.4) 12 (8.8) –
5 (3.6) 10 (7.3) 13 (9.5) 14 (10.2) –
– 3 (2.2) 12 (8.8) 4 (2.9) 15 (10.9)
5 (3.6) 11 (8.0) 13 (9.5) 25 (18.2) 7 (5.1)
1 (0.7) 21 (15.3) 21 (15.3) 14 (10.2) 7 (5.1)
– 10 (7.3) 12 (8.8) 11 (8.0) 8 (5.8)
– 11 (8.0) 11 (8.0) 5 (3.6) 10 (7.3)
4 (2.9) 21 (15.3) 16 (11.7) 14 (10.2) 8 (5.8)
4 (2.9) 15 (10.9) 13 (9.5) 4 (2.9) 12 (8.8)
Table 3
Antimicrobial use and prescribing-related antimicrobial stewardship activities.
Antimicrobial use and prescribing-related activities No. of Respondents - %s in
brackets
Perceived success of the activity (only those who answered “Yes” to having the activity
at their institution - with %s vs. total in brackets)
Don't
know
No Yes Unsuccessful Somewhat
successful
Moderately
successful
Very
successful
Extremely
successful
Provision of clinical pharmacy services 3 (2.2) 44
(32.1)
90
(65.7)
11 (8.0) 22 (16.1) 27 (19.7) 22 (16.1) 8 (5.8)
Provision of consult service by Infectious Diseases
Clinicians
12 (8.8) 34
(24.8)
91
(66.4)
17 (12.4) 24 (17.5) 23 (16.8) 21 (15.3) 6 (4.4)
Streamlining or de-escalation of therapy (i.e. treatment
is re-directed after culture results have been obtained)
3 (2.2) 51
(37.2)
83
(60.1)
2 (1.5) 23 (16.8) 20 (14.6) 24 (17.5) 14 (10.2)
Use of clinical guidelines to guide antimicrobial
prescribing
13 (9.5) 30
(21.9)
94
(68.7)
2 (1.5) 33 (24.1) 35 (25.5) 20 (14.6) 14 (10.2)
Program for timely conversion of IV to oral
antimicrobials
5 (3.6) 50
(36.5)
82
(59.5)
– 32 (23.4) 19 (13.9) 20 (14.6) 11 (8.0)
Use of phone-based approval system for antimicrobial
prescribing
3 (2.2) 93
(67.9)
41
(30.0)
2 (1.5) 15 (10.9) 13 (9.5) 5 (3.6) 6 (4.4)
Regular multidisciplinary antimicrobial stewardship
ward round to some wards or for certain patient
groups
8 (5.8) 89
(65.0)
40
(29.2)
2 (1.5) 15 (10.9) 5 (3.6) 12 (8.8) 6 (4.4)
Use of a sticker to notify prescribers regarding the need
to obtain approval for antimicrobial prescribed
1 (0.7) 114
(83.2)
22
(16.1)
– 12 (8.8) 4 (2.9) 6 (4.4) –
Use of automatic ‘stop orders’ for antimicrobials
prescribed
1 (0.7) 98
(71.5)
38
(27.7)
2 (1.5) 8 (5.8) 17 (12.4) 3 (2.2) 8 (5.8)
Use of electronic antimicrobial prescribing approval
systems
2 (1.5) 114
(83.2)
21
(15.3)
2 (1.5) 4 (2.9) 2 (1.5) 1 (0.7) 12 (8.8)
Rotation of selected antimicrobial drugs within a
speciﬁc timeframe
12 (8.8) 64
(46.7)
61
(44.5)
3 (2.2) 15 (10.9) 19 (13.9) 17 (12.4) 7 (5.1)
Implement Interventions to Reduce the Risk of
Antibiotics Associated Clostridium Difﬁcile Infection
18
(13.1)
66
(48.2)
53
(38.7)
3 (2.2) 17 (12.4) 8 (5.8) 16 (11.7) 9 (6.6)
Implement Strategies That Promote Cycling or Mixing in
Antibiotic Selection to Reduce Antibiotic Resistance
7 (5.1) 55
(40.1)
75
(54.7)
6 (4.4) 23 (16.8) 20 (14.6) 19 (13.9) 7 (5.1)
Dedicated Pharmacokinetic (PK) Adjustment/TDM
Program Lead to Improved Clinical Outcomes and
Reduced Costs
8 (5.8) 94
(68.6)
35
(25.5)
– 9 (6.6) 7 (5.1) 11 (8.0) 8 (5.8)
Advocate C-Reactive Protein (CRP), Procalcitonin (PCT)
Testing
19
(13.9)
74
(54.0)
44
(32.1)
2 (1.5) 7 (5.1) 12 (8.8) 11 (8.0) 12 (8.8)
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working in tertiary hospitals [23]. The present study also showed that
four-ﬁfths of facilities failed to participate in the national antimicrobial
utilization surveillance program, indicating that the data generated in
that program may not be representative of the nation as a whole.
Moreover, this survey also highlighted that the success rate of antimi-
crobial stewardship activities is very low, which needs to be addressed
going forward.
The study also showed discrepancies in standard approaches to ASPs
that need to be addressd in Pakistani hospitals in the future. The pub-
lished literature documents that pharmacist services are frequently used
to rationalize dosing, implement IV-to-oral switching or support post-
prescription reviews to improve future antibiotic use in hospitals,
while infectious disease specialists are essential for diagnostic input and
ward rounds [24]. However, the possible valuable role of nurses in ASP is
typically underestimated [25].
In this present study, it was also noted that in most hospitals, there
were limited diagnostic facilities and that the availability of reagents and
development of antibiogram was uncommon. This is a concern and
suggests prescribing of antimicrobials was mainly empiric. In addition, as
the role of the medical microbiologist and the microbiology laboratory
are central to any ASP, mainly through the development of antibiograms
[26], with increasing use of diagnostic interventions shown to decrease
the burden of unnecessary antimicrobial use [27]. Antimicrobial stew-
ardship ward rounds have also been regularly used to reduce irrational
antimicrobial prescribing and pharmacy cost as well as reduce infection
rates and AMR [28]. Our study results suggest that most of the hospitals
taking part did not have institutional prescribing guidelines. However,
encouragingly, the approval of restricted formulary for antimicrobials
through DTCs or equivalent committees within the hospital and regular
auditing of antimicrobial prescribing and use was common among the4participating hospitals. This means themajority of hospitals have DTCs to
be able to inﬂuence prescribing as we see in other countries [29, 30]. We
are also aware that regular audituing and feedback have beenused to
successfully as a cost effective way to restrict the use of broad-spectrum
antibiotics [31]. Antibiotic mixing or cycling strategies have also occa-
sionally been reported, probably reﬂecting the practical problems in
undertaking this, including scarcity of evidence to support mixing and
considerable use of resources [32, 33]. . In addition, the effective use of
multidisciplinary models for implementing ASPs helps achievethe
required outcomes. Competency and outcomes based lectures, work-
shops, lunchtime presentations, face–to–face interventions, e-learning
and other possible educational framework for doctors, nurses and phar-
macists are useful in planning the implementation of ASPs [11]. How-
ever, there is a need to focus on a minimum set of achievable targets,
which is especially relevant to Pakistan. In addition, address the major
issue of diagnostic facilities and professional advice through microbiol-
ogists and infectious disease specialists.
We are aware that there are several limitations of our survey. First,
the recruitment of respondents was through professional associations and
contact sources of the authors, contributing to potential recruitment bias.
Second, there was a difference between the regions in terms of reporting
results. The number of returns from central Punjab was high and well-
representative as compared to north and south Punjab. Third, as most
of the surveys were addressed to Chief Pharmacist or their nominees, the
responses received could have been biased towards the pharmacists'
perspectives. Fourth, there could be self-bias, particularly in case private
sector hospitals, either not willing or incorrect information. We also did
not collect the complete data of hospital demography including the
number of beds, number of admissions/day, number of intensive care
units, laboratory testing capacity. Last, there was only a moderate
response rate and we only induded hospitals in Punjab limiting the
Z. Saleem et al. Heliyon 5 (2019) e02159generalizing of the results to all hospitals in Pakistan. Never-the-less, we
believe that in view of our methodology the ﬁndings are rov ¼ bust and
provide clear direction to improve the use of antimicrobials in hospitals
in Pakistan in the future.
5. Conclusion
The study inferred that there are inadequate ASPs among the hospi-
tals of Pakistan. A multidisciplinary approach, clinical leadership and the
availability of enthusiastic and motivated individuals are essential ele-
ments for the success of ASPs. Adequate clinical pharmacy and infectious
disease resources should be made available by the government to support
ASPs in the future as the government moves forward with its strategy to
reduce AMR rates in Pakistan. We hope that this work will inform local
and international policy-makers about current stewardship activities and
challenges with a view to foster broader international collaboration as
recommended by the WHO.
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